Lingjian Yang
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer-related molecular mechanisms research, RNA modifications and cancer, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research
Most-Cited Works
- → Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer(2018)156 cited
- → A regression tree approach using mathematical programming(2017)140 cited
- → Mathematical programming for piecewise linear regression analysis(2015)129 cited
- → A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients(2017)128 cited
- → Srs11‐92, a ferrostatin‐1 analog, improves oxidative stress and neuroinflammation via Nrf2 signal following cerebral ischemia/reperfusion injury(2023)96 cited
- → Reconstruction and analysis of correlation networks based on GC–MS metabolomics data for young hypertensive men(2014)92 cited
- → Long-Term Outcomes of Radical Radiation Therapy with Hypoxia Modification with Biomarker Discovery for Stratification: 10-Year Update of the BCON (Bladder Carbogen Nicotinamide) Phase 3 Randomized Trial (ISRCTN45938399)(2021)72 cited
- → Danshensu Inhibits β-Adrenergic Receptors-Mediated Cardiac Fibrosis by ROS/p38 MAPK Axis(2014)65 cited
- → Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts(2017)48 cited
- → Hypoxia gene expression signatures as predictive biomarkers for personalising radiotherapy(2018)46 cited